Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate Capsule, Extended Release
Product Images NDC 43975-282

7 FDA label images from Ani Pharmaceuticals, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate And Amphetamine Sulfate (NDC 43975-282). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure-1 (Image 01)

Figure-1 (Image 01)
A line graph depicting mean plasma concentrations of dextroamphetamine and levoamphetamine over 24 hours after administration of extended-release capsules and tablets containing a combination of dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate, and amphetamine sulfate. The x-axis represents time in hours, and the y-axis shows mean plasma concentration in ng/mL, comparing different dosage forms and dosing schedules.*
FDA Label Image

Label-5mg (Image 05)

Label-5mg (Image 05)
Label for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate extended-release capsules. The strength shown is 5 mg per capsule. The label indicates the product contains mixed salts of a single-entity amphetamine product and is classified as Schedule II (CII). The package quantity is 100 capsules, manufactured for Amerigen Pharmaceuticals, Inc., with NDC 43975-277-10. Additional information includes storage instructions and dispensing guidance for pharmacists.*
FDA Label Image

Label-10mg (Image 06)

Label-10mg (Image 06)
Label for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules, 10 mg strength, supplied in a bottle of 100 capsules by Amerigen Pharmaceuticals. The label indicates it is a Schedule II controlled substance and includes dosage information, storage instructions, and a barcode with manufacturer details from Amerigen Pharmaceuticals, Inc., Lyndhurst, NJ.*
FDA Label Image

Label-15mg (Image 07)

Label-15mg (Image 07)
Label for 15 mg Extended-Release Capsules of Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate, and Amphetamine Sulfate, mixed salts of a single-entity amphetamine product. The label shows NDC 43975-279-10, quantity of 100 capsules, and is manufactured for Amerigen Pharmaceuticals, Inc. It includes storage and dosage instructions and a barcode with lot and expiration placeholders.*
FDA Label Image

Label-20mg (Image 08)

Label-20mg (Image 08)
Label for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate extended-release capsules 20 mg, 100 count, manufactured for Amerigen Pharmaceuticals, Inc. The label lists active ingredient amounts and storage instructions, and includes the NDC 43975-280-10, barcode, and QR code. It also states the product is a Schedule II controlled substance (CII) and prescription only.*
FDA Label Image

Label-25mg (Image 09)

Label-25mg (Image 09)
Label for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate extended-release capsules, 25 mg strength, containing 100 capsules. The label shows it is a Schedule II controlled substance (CII), distributed by Amerigen Pharmaceuticals. Dosage components and storage instructions are detailed, including amphetamine base equivalence of 15.6 mg. The label includes NDC 43975-281-10, barcode, and lot/expiration placeholders.*
FDA Label Image

Label-30mg (Image 10)

Label-30mg (Image 10)
Label for Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate Extended-Release Capsules 30 mg. The label shows it is a Schedule II controlled substance with NDC 43975-282-10 in a package of 100 capsules, manufactured for Amerigen Pharmaceuticals, Inc., Lyndhurst, NJ. It lists active ingredient amounts and storage instructions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.